These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10623754)

  • 21. Apropos "neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in non-human primates".
    Arya SC; Agarwal N
    Vaccine; 2008 Aug; 26(35):4413. PubMed ID: 18602962
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous gene expression from transmissible gastroenteritis virus replicon particles.
    Curtis KM; Yount B; Baric RS
    J Virol; 2002 Feb; 76(3):1422-34. PubMed ID: 11773416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells.
    Petrakova O; Volkova E; Gorchakov R; Paessler S; Kinney RM; Frolov I
    J Virol; 2005 Jun; 79(12):7597-608. PubMed ID: 15919912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.
    Gardner CL; Burke CW; Tesfay MZ; Glass PJ; Klimstra WB; Ryman KD
    J Virol; 2008 Nov; 82(21):10634-46. PubMed ID: 18768986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice.
    Schoneboom BA; Lee JS; Grieder FB
    J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venezuelan equine encephalitis.
    Weaver SC; Ferro C; Barrera R; Boshell J; Navarro JC
    Annu Rev Entomol; 2004; 49():141-74. PubMed ID: 14651460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo.
    Konopka JL; Penalva LO; Thompson JM; White LJ; Beard CW; Keene JD; Johnston RE
    PLoS Pathog; 2007 Dec; 3(12):e199. PubMed ID: 18215114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation.
    Anishchenko M; Bowen RA; Paessler S; Austgen L; Greene IP; Weaver SC
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4994-9. PubMed ID: 16549790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
    Kinney RM; Esposito JJ; Johnson BJ; Roehrig JT; Mathews JH; Barrett AD; Trent DW
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3005-13. PubMed ID: 2462013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
    Grieder FB; Vogel SN
    Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes.
    Woodward TM; Miller BR; Beaty BJ; Trent DW; Roehrig JT
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2431-5. PubMed ID: 1919525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.
    Charles PC; Walters E; Margolis F; Johnston RE
    Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters.
    Jackson AC; SenGupta SK; Smith JF
    Vet Pathol; 1991 Sep; 28(5):410-8. PubMed ID: 1750167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocytes as targets for Venezuelan equine encephalitis virus infection.
    Schoneboom BA; Fultz MJ; Miller TH; McKinney LC; Grieder FB
    J Neurovirol; 1999 Aug; 5(4):342-54. PubMed ID: 10463856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
    Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE
    Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epitope specificity and protective activity of monoclonal antibodies to Venezuelan equine encephalomyelitis virus].
    Shpilevaia MV; Kush AA; Razumov IA; Arkhipov VN; Tsilinskiĭ IaIa; Loktev VB
    Vopr Virusol; 1995; 40(2):82-5. PubMed ID: 7539195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus.
    Johnston RE; Smith JF
    Virology; 1988 Feb; 162(2):437-43. PubMed ID: 3341117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.